Peer Review Article on the Us Drug War

1 Introduction

The administration of opioids has been used for centuries equally a viable option for pain management.^[one] Literature reported in 2016 that approximately 100 meg people suffer from hurting in the United States (U.s.), nine to 12 million of them reported chronic pain while the residue reported short-term pain from injuries, diseases, and/or medical procedures.^[two] When administered at appropriate doses, opioids prove effective at not only eliminating pain simply further preventing its recurrence in long-term recovery scenarios.^[iii] Physicians take complied with the advisable management of acute and chronic pain; however, this curt or long-term opioid exposure provides opportunities for long-term opioid misuse and corruption, leading to habit of patients who receive an opioid prescription and/or diversion of this pain medication to other people without prescription.^[2,4,5] In the final 25 years, opioid misuse, over-prescription, and unauthorized distribution have run rampant in the The states, resulting in growing evidences of opioid prescription abuse and dependence disorders, not-medical use of pharmaceutical opioids and accidental overdose death rates at levels unseen before in the US.^{[iv,half dozen,vii]} Around half dozen% of the US population (15–64 years onetime) reported some type of opioid abuse, and an estimated deaths of 115 United states of america citizens per twenty-four hour period due to opioid overdose have been reported in 2015.^[7] Devastating implications for the medical infrastructure and healthcare organization will arise if this problem is not resolved in the coming decade.^[2] The current literature related with hurting and opioid misuse confirms controversial incidence, associated factors, and potential approaches to control this problem. Several reviews attempted to summarize the epidemiology and management of opioid misuse, this integrative review seeks to summarize the current literature related with responsible parties of this opioid abuse crisis and discuss potential associations betwixt demographics (ethnicity, culture, gender, faith) and opioid accessibility, abuse, and overdose.

2 Methods

We performed an all-encompassing literature search in Google Scholar and Pub Med databases that were published between December 7, 1999 and January nine, 2018 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines.^[8] Searches were referenced using medical subject field headings (MeSH) that included "opioids", "over-prescription", "opioid consumption", or "opioid epidemic". Two authors screened independently the search results for eligibility and reviewed the selected manufactures if they were: related with crunch of prescription opioid of other illicit opioid misuse, focused on the US population and published in the English language. The manuscripts were excluded if they were: abstract publications, reviews of non-chief research, specific to specific hurting (e.g., palliative pain), example reports, series of example reports, focused on the evaluation of a specific opioid brand and non-English. The last review of all information bases was conducted on July 24, 2018.

3 Results

A total of 7160 manufactures were originally identified from our information base search. After 3340 duplicate articles were removed, 3820 manuscripts were removed after title and abstract screening. Post-obit this, 120 manuscripts underwent eligibility pick with only lxx publications beingness selected as reliable full-texts addressing a variety of influencing factors surrounding the opioid crisis (Fig. i). Amongst these 70 publications, we found 12 articles with data from a significant amount of patients and an abbreviated compilation of demographic profile and outcomes/implications from these sources can be found in Table i.

Figure 1:

PRISMA flow chart diagram of manuscripts selection. PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analysis.

Tabular array i:

Characteristics and overview of scientific manuscripts reviewing opioid consumption crisis.

iv Give-and-take

Our review identified several associated factors that are direct or indirectly related to the current opioid abuse crunch in the Usa. The identification of these factors could heighten our knowledge and understanding of the trends of this crisis and potential solutions that are crucial to the design of new policies and healthcare reform plans to properly reduce and/or somewhen solve this trouble.

4.ane Demographics and United states of america regional distribution

Opioids were responsible for 66.4% of total overdoses in the year 2016.^[nine] From a demographic perspective, although this increase affected all ethnic groups, non-Hispanic whites experienced the most devastating increase with adults ages 45 to 54 suffering the highest rates of mortality according to the National Middle for Health Statistics.^[ten] At that place is a significant number of bipolar and schizophrenic patients abusing opioids when compared with the general clinical population (P <.001).^[11] The study reported that a college proportion of men than women are testing positive for substance employ disorder (SUD), including opioid employ disorder (OUD) (77% vs 44%).^[eleven]

Due to the high relapse rates among opioid-dependent patients, strategies such as positive religious coping, reducing opioid consumption, and increasing participation in related programs may exist utilized for recovery handling.^[12] Negative religious coping is also associated with lower relapse rates.^[12,13] Taking into account the vast amount of cultural multifariousness in the Us, organized religion, and spirituality remain sensible subjects for physicians to discuss when addressing opioid addiction.^[12,13] Opioid-related overdose is a leading cause of unintentional injury and thus adds pregnant financial and resources burden to hospital systems. From 2001 to 2012, more than 660,000 hospitalizations in the US were attributed to opioid overdose, which accrued more than $700 million healthcare dollars annually.^[14]

By region, prescription opioid overdose-related (POD) hospitalizations were highest in the S region while heroin overdose (HOD)-related hospitalizations were highest in the Northeast and Midwest regions.^[15] By customs, hospitalizations due to HOD were higher in urban areas compared to rural areas (5.5 per 100,000 vs 2.one per 100,000 in 2014).^[16] In dissimilarity, POD hospitalization rates were xxx% higher in rural compared to urban populations.^[16]

The state of Ohio has been known as an opioid battleground for many years, boasting the fifth highest rate of overdose in the United states of america (2017).^[17] An Opiate Activity Squad was founded in 2011 to reduce the amount of drugs being prescribed, educate the population and increase availability of naloxone.^[18] The region saw a decrease in the corporeality of opioid-related overdoses during the menstruum of 2011 to 2015 from 45% to 22%.^[17]

4.2 Opioid epidemic

The Center of Disease Control and Prevention (CDC) defines an epidemic as, "the occurrence of more cases of illness than expected in a given area or among a specific group of people over a detail period of time,".^[19] While the abuse of prescription pills is not a disease, addiction is.^[20] The hotbed of occurrences originates in the U.s.a., which has the highest charge per unit of abuse in the world.^[21] This specific outbreak is the worst drug abuse cycle the The states has ever seen and is listed past the CDC as a top 5 public health claiming.^[21] Since 2000, the incidence of expiry from drug overdose has tremendously increased (137%, including 200% of deaths related to opioids).^[22] The CDC reported a total of 63,632 opioid overdose deaths in 2017 in the U.Due south., with an increment of 45.ii% for synthetic opioid-involved overdose from 2016 to 2017; hence this epidemic continues to illustrate its severity and considerable threat to the health of American citizens.^[22–24] Yet, a potent effort has been made to subdue the problem. Opioid prescriptions were reduced by 13.1% from 2012 to 2015 as a result of doc awareness and implementation of new policies.^[25] One detail written report displayed a thirty% reduction in opioid prescriptions for hurting direction equally a result.^[26]

4.3 Shifting patterns from prescription opioids and heroin abuse

The high charge per unit of opioid prescription in the U.s.a. (effectually fifty,000 prescriptions/one thousand thousand inhabitants, places us start in the world, in comparison to other high-income countries; With Canada being the second opioid prescriber with a much lesser value (around thirty,000 prescriptions/1000000 inhabitants) from 2012 to 2014.^[27,28] Coupling this with the leniency that exists regarding the regulation of the actions of pharmaceutical companies, the trouble quickly grew out of control.^[29] Adult tolerance to these easily accessible and addictive drugs results in users seeking a more cost-effective drug in order to reach similar results.^[30]

The most prescribed opioids in the US include hydrocodone (a constituent in Vicodin, Lortab, Zohydro, and other commercial-proper name drugs), oxycodone (a elective in Oxycontin and Percocet), and morphine.^[31] The easy access to prescription opioids by the general public has shifted the trends of addiction by introducing consumers to other forms of opioid drugs such as heroin and other illegal opioid formulations, aggravating the trouble by creating an interaction between the two.^[28]

four.3.1 Oxycodone

The shift to opioids being considered a national health business concern started with the promotion of drugs like oxycodone past Purdue Pharma, with a bonus organization applied to the sales of the drug in an attempt to influence prescription rates.^[32] A marketing database with data nigh prescribing trends of physicians across the US was afterwards created.^[32] Promotional campaigns of oxycodone portrayed the chance of addiction as an insignificant business concern as sales increased exponentially during that time flow.^[32]

4.3.two Synthetic opioids

Synthetic opioids (SOs) are a course of drugs commonly used for pain management due to their power to mimic the pharmacologic pathway of true opioids such as morphine and codeine (Figure A).^[33] These SOs have flooded the market in the past decade from both pharmaceutical companies and illegal sources, representing a major contribution to the opioid crisis.^[34] Karila et al referred to constructed pharmaceutical and not-pharmaceutical fentanyl that go far illegally from main exporting countries such equally China and United mexican states and can exist readily available on the net at low prices and high purity.^[35] There is limited data on the pharmacological properties of many SOs, which just require pocket-sized doses to produce an consequence, leading to a high-risk for overdose or harmful physiological and psychiatric complications.^[36] SOs accounted for 19,000 deaths in the US in 2016, more than whatever other grade of opioid drug.^[34] Additionally, SOs accounted for 31% of all deaths due to drug poisoning in 2016 according to the Drug Enforcement Administration (DEA), underlying the increase in their availability and popularity on the street.^[36] The DEA reports a dramatic ascension in the tablet class of SOs seized, suggesting the inclusion of prescription opioid users in the market for fentanyl.^[36]

four.3.three Heroin gateway

Heroin has gained significant consideration in media outlets in the past decade equally its recreational use has become an outcome of national attention. A 2014 study found that for users of both opioids and heroin, the average kickoff appointment of opioid usage was 2005 compared to a start date of 2008 for heroin, suggesting that the abuse of opioid medication may lead to future use of heroin.^[37] A review initiated by Cicero et al demonstrated a significant shift from the 1960s to the early 2000s in regards to the method of opioid introduction.^[38] Heroin was often the initial opioid driveling past individuals in the 1960s with opioids often serving as a gateway at the turn of the century.^[38] Arrival of heroin into the US at present predominantly arises from the Mexican and Colombian markets, affecting different geographical areas with a downward trend in their pricing on the street.^[39] The complicated nature of the heroin problem in the U.s. involves market structure and distribution.^[xl] A study conducted by Mars et al in 2015 analyzed these parameters in Philadelphia and San Francisco. Philadelphia'southward open drug markets and the existing competition drives the toll of the product down.^[forty] This leads to purity-based competition, causing a college risk of overdose in afflicted communities.^[twoscore]

4.iv Over-prescription

Health intendance providers' over-prescription is one of the leading factors of addiction.^[41] Commonly prescribed drugs such every bit hydrocodone and oxycodone take risen from 76 million prescriptions in 1991 to roughly 207 million in 2013.^[42] According to data from the CDC, the total number of opioid prescriptions has decreased since 2012, with a low of most 215 one thousand thousand total annual prescriptions in 2016.^[43] A written report conducted by Liu et al establish that out of 3,391,599 patients who were prescribed opioids past medical providers, almost 25% displayed characteristics of personal misuse (recreational use).^[44] The study concluded that the boilerplate patient was administered iii different prescriptions lasting an average of 47 days with opioid and benzodiazepine overlapping.^[44]

This tendency of abuse is non merely affecting adults; adolescents and children are affected besides and contribute heavily to the problem.^[45] Easy admission to prescription opioids in American households has led to more than frequent opioid overdose among children.^[46] The largest increase in hospitalization rates for opioid overdose between 1997 and 2012 was reported for children aged ane to 4 on a retrospective assay obtained from pediatric infirmary belch records across the US.^[47] A study population of 7374 loftier school seniors found that 12.nine% had used opioids recreationally and that eighty% of these nonmedical uses originated from previous prescriptions.^[48]

four.5 "Doctor shopping"

Another common method of procuring opioids is "doctor shopping" which occurs when multiple providers are visited in order to gain a surplus of medication.^[49] New prescription drug monitoring programs (PDMPs) have been adult as a response to this event in an effort to eradicate this form of exploitation.^[50] Near states have just started implementing PDMPs within the last 10 years, increasing from 16 to 49 states from 2001 to 2012.^[51] These programs provide physicians with an electronic database that entails the prescription history of each patient that can exist checked before and after a new prescription is written.^[51] A written report accessing information from the National Survey of Drug Use and Health (NSDUH) proved the usefulness of creating and using databases when addressing "md shopping" for opioid prescriptions in 36 states.^[51] Additionally, extended-release opioids have proven to exist a useful alternative compared to traditional release opioids due to their less addictive nature and lower rates of corruption.^[52] A survey conducted past Cicero et al demonstrated a greater preference for instant release (95%) than extended release due to the immediate consequence of the drug.^[53]

iv.6 Distribution

The fashion of opioid distribution in the US is perhaps the root of the large-scale problem the U.s. now faces.^[54] Betwixt 26 and 36 1000000 individuals abuse opioids worldwide with overdose deaths in the US quadrupling since 1999.^[54] The caste of economic strain the litany of abuses places on afflicted communities is impressive and trending in the wrong management. Just 10 years ago, the full cost of opioid-related abuses on communities was estimated to be 55.7 billion dollars.^[55] Ten years later, the problem has slipped even farther out of control.

Opioids are "powerful hurting-reducing medications" used to care for postoperative hurting following surgery.^[56] A prospective study published by Rodgers et al (2012) raised awareness concerning the excessive number of opioid pills ("leftover medication") prescribed for patients undergoing hand and wrist surgeries.^[57] A more recent study assessed the opioid prescription for partial mastectomy and laparoscopic inguinal hernias with 90.five% of the patients being prescribed opioids.^[58] The authors commented on the large excess of pills prescribed and the lack of disposal for opioid surplus, with but 5% returning their medications to a collection site canonical by the Federal Drug Agency.^[58]

4.seven Healthcare and insurance responsibility

It is estimated that the full toll placed on the United states of america healthcare infrastructure involving opioids is $72.5 billion annually.^[59] Coverage for at-adventure individuals often supports the prescription of opioids rather than other time-consuming pain relief alternatives.^[60,61] These alternatives, such every bit interdisciplinary treatment programs, accept proven to exist clinically efficacious.^[lx,61] Unfortunately, these programs have decreased in number beginning in the early on 2000s due to sparse coverage on insurance plans.^[60,61] Several studies back up the cost-efficiency of such programs despite the ambitious coverage drops exhibited by near insurance companies.^[60,61] Nevertheless, they have largely replaced these alternative programs to cover the use of opioids with a loftier potential for corruption.^[60,61] The immediate impact of this trend was quickly observed when methadone was found responsible for one-third of opioid fatalities, despite representing only 5% of opioids prescribed, from 1999 to 2010.^[60] The American Medical Association, the American Society of Anesthesiologists and the American College of Physicians have supported the utilise of not-opioid pharmacologic therapy every bit a preferable alternative.^[62]

There is a correlation betwixt cost direction, profitability and the coverage provided to Americans by wellness care providers that practise not respect the personal wellness of consumers.^[63]

Additionally, financially incentivized coverage decisions made by health care providers twenty years ago play a role in the opioid crisis seen today in the Usa.^[63]

4.eight Legal implications

Efforts to reform opioid-overdose legislation in sure states, including Practiced Samaritan laws and increased naloxone access, have been associated with reduced bloodshed rates.^[64] Yet, suppressive policies towards supply and consumption of opioids continue to exist the norm, aggravating the trouble of illegal sale on the black market.^[65] Criminalization of opioids creates a potent stigma towards certain societal groups including pregnant women, as legal consequences of opioid abuse when significant deters women from seeking treatment and damages patient-physician relationships.^[66] The devastating social impact of opioids straight affects impoverished families, as opioid-related deaths are correlated with poverty, even though prescription rates are lower for poorer communities.^[67]

Many users choose to obtain narcotics via drug dealers; either in person or online.^[68] Online drug dealings open up the door to increased risk of overdose and death due to contamination with alternate substances or a higher authority than advertised.^[68] A 2012 study surveying l drug dealers found that the major drugs being dealt were indeed opioids, specifically oxycodone and hydrocodone.^[69] Only over half of respondents disclosed access to clinics that loosely prescribed the opioids.^[69] As previously discussed, the monthly "dr. shopping" technique was used at four to 5 clinics on average in order to refill the dealer's various prescriptions.^[69] Of those surveyed, 44% described purchasing medication in their customs from patients with existing prescriptions as their preferred method of access.^[69] While recreational use stemming from leftover prescriptions remains the almost common method, McCabe et al reported a 38% response rate concerning the purchase of opioids from a friend or relative.^[lxx] Obtaining these drugs from a drug dealer only accounted for nineteen.four% of surveyed sales.^[lxx]

Legislation exists in the Usa that outlaws the unauthorized sale of narcotics online, still, these sales find ways to occur.^[71] Sellers are able to do concern using online markets and are adept at shipping and delivering the drugs anonymously to buyers.^[72] The "dark web" is a common term for the immense department of the net that is accessed by browsers specialized in anonymity.^[73] As a upshot, competent drug dealers who sympathise how to use this section of the net have access to high-quality drugs that tin be purchased for resale.^[73]

4.9 Media influence

Media portrayal of the opioid crunch has influence on the perception of the issue past American citizens.^[74] While media outlets accept historically correlated drug use to disadvantaged minorities, this has not proved to be the case.^[74] Examples of opioid misuse have involved white, centre class, rural Americans.^[75] Still, tendencies to target minority doctors when running segments on prescription negligence have been observed.^[74] Spikes in opioid media coverage arise in response to celebrity deaths, major federal trials, and pharmacological headlines.

Media outlets were the commencement to run stories about prescription misuse earlier many government-run programs were able to detect the scale of the problem.^[75] A 2015 study addressed news headlines from 1990 to 2010 with data suggesting that media outlets had attempted to portray the outcome equally an isolated criminal justice problem instead of a widespread public wellness concern.^[76] Headlines commonly focused on drug dealing, arrests, and prosecution.^[76] Treatment and recovery options accounted for less than v% of all media headlines.^[76]

4.10 Rehabilitation

Lack of solutions for the increasing overdose deaths has led to alternating forms of therapy. A multimodal approach to handling selects patients according to their risk level.^[18] In order to manage chronic pain, therapy focuses on multimodal pharmacologic treatment coupled with behavioral approaches devised for long-term management with periodic monitoring of patients.^[eighteen]

Opioid agonist treatments (OATs) are preferred due to evidence of effectiveness over abstinence-based approaches when considering patient safety and treatment retention.^[77] The appropriate treatment should be chosen with careful consideration of method of ingestion, variety of opioids, historic period, health status, psycho-social factors, and personal preferences. Methadone tends to prove higher handling retentivity rates and is advised for specific groups such as youth and pregnant women, whereas buprenorphine-naloxone has a lower risk of overdose for patients with ongoing handling for a psychiatric disorder or low tolerance for opioids.^[77] A written report conducted in 2015 by Clark et al plant that expenditure was considerably higher for behavioral treatments than OATs, which also showed 50% lower relapse risk.^[78] Additionally, the study assessed risk factors for relapse, including comorbidities, showing an 80% greater risk for patients that were diagnosed with schizophrenia and bipolar disorder in manic phase.^[78]

4.11 Clinician instruction

The about important counter to the opioid crisis is arguably the education of healthcare providers, consumers, and at-risk individuals. Due to inadequate results stemming from guidelines and programs, the resulting large scale problem has driven governments to call for change.^[79] The take chances evaluation and mitigation strategy (REMS) was implemented in 2012 and mandated that opioid manufacturers be required to fund prescription didactics programs too as healthcare providers providing prescription data to state monitors.^[79] A contempo article published by Wiese et al discusses the evolution of "upstream" educational programs for a meliorate understanding of the factors involved in opioid over-prescription, and a more sustainable approach to prescription that instructs future physicians at all levels of their instruction.^[79] A clear distinction is made between "upstream" and "downstream" treatments in the course of federal regulations which are ineffective in terms of long-term behavior change and can contribute to md burnout and moral distress.^[79]

4.12 Barriers to opioid crunch control

Despite the damage inflicted by the current opioid epidemic, there is withal a lack of research and public investment on areas such as opioid pain management or agreement the nature of opioid apply disorder in the U.s.a..^[80] Several problems have been identified as cardinal limiting factors in basic pain research, such as option of adequate pain models, that restrict the reproducibility of the results and ultimately waste research funding.^[80] The extensive utilise of opioids and the epidemiology of the problem in the United states of america has been adequately studied, but more than information on the evolution of acute and chronic pain and how this leads to preferential opioid employ is necessary to increase our understanding of opioid-related morbidity and mortality. The increase in budget funds received by the National Establish of Wellness (NIH) in 2018 targeted towards opioid inquiry should support the implementation of strategies to address the abuse and enhance treatment procedures for chronic hurting, a condition that received less than two% of the NIH'southward almanac budget before 2018 despite being and so prevalent in the U.s. population.^[81,82]

5 Conclusion

While the appropriate use of opioids is an essential aspect of modern analgesia, in that location is no denying that the misuse and abuse of these drugs accept allowed this problem to screw out of control.^[3] With approximately 100 million people suffering from both chronic and acute hurting in the US in 2016, opiates will keep to remain a prominent grade of medication in healthcare facilities and homes across the US.^[2] Over 66% of total overdose episodes in 2016 were opioid-related, a effigy that attests to the severity and wide-spread nature of this issue.^[nine] The unfortunate reality is that no finger can exist pointed at ane singular culprit, as each of the parties mentioned in this review has their share of influence and culpability by which this complex trouble has evolved. The singled-out associations between demographical categories (ethnicity, culture, gender, religion) and accessibility, abuse, and overdose are simply pieces of the puzzle that contain this complex epidemic. A 3-point approach accentuating the prevention, treatment, and rehabilitation of both those currently affected and at-risk in the hereafter may be the comprehensive solution. Farther investigation of the nature of OUDs, demographical factors, rehabilitation programs and new strategies dedicated to managing an opioid crisis is required in lodge to finer respond to a similar claiming in the future.^[80]

Acknowledgments

Nosotros admit the contribution on the terminal phase of editing of our 2nd year, Ohio State University College of Medicine medical educatee, Kenna Koehler.

Author contributions

NS, AU, TW, and SB participated in blueprint, methodology and manuscript edit. Ac and LP participated in literature search, information collection, and manuscript editing.

Conceptualization: Nicoleta Stoicea, Tristan Weaver, Sergio D Bergese.

Methodology: Nicoleta Stoicea, Alberto Uribe.

Projection assistants: Nicoleta Stoicea, Alberto Uribe.

Supervision: Nicoleta Stoicea, Alberto Uribe, Sergio D Bergese.

Validation: Nicoleta Stoicea, Alberto Uribe.

Writing – Original Draft: Luis Periel, Andrew Costa.

Writing – Review & Editing: Nicoleta Stoicea, Luis Periel, Andrew Costa, Alberto Uribe, Tristan Weaver, Sergio D Bergese.

References

[1]. Yim N, Parsa FD. From the origins of the opioid utilize (and misuse) to the challenge of opioid-costless pain direction in surgery. Pain Treat 2018;IntechOpen. i-10.

• Cited Hither

[2]. Califf RM, Woodcock J, Ostroff S. A proactive response to prescription opioid abuse. New Engl J Med 2016;374:1480–5.

• Cited Here

[3]. Niewijk Chiliad. Ancient Analgesics: A brief history of opioids [Internet]. Yale Scientific Magazine. Yale Scientific Magazine - http://www.yalescientific.org; 2017 [cited May 5, 2019]. Bachelor from: http://world wide web.yalescientific.org/2017/01/ancient-analgesics-a-brief-history-of-opioids/.

• Cited Here

[iv]. Anderson T. Curbing prescription opioid dependency: an epidemic of overdoses and deaths from opioids is fuelled past increased prescribing and sales in N America. Bull Earth Health Organ 2017;95:318.

• Cited Hither

[5]. Feinberg AE, Chesney TR, Srikandarajah S, et al. Opioid utilise after discharge in postoperative patients: a systematic review. Ann Surg 2018;267:1056–62.

• Cited Here

[6]. Carlson RG, Nahhas RW, Martins SS, et al. Predictors of transition to heroin use amid initially non-opioid dependent illicit pharmaceutical opioid users: a natural history report. Drug Alcohol Depend 2016;160:127–34.

• Cited Here

[7]. Theisen 1000, Jacobs B, Macleod 50, et al. The U.s.a. opioid epidemic: a review of the surgeon's contribution to information technology and wellness policy initiatives. BJU International 2018;122:754–nine.

• Cited Here

[8]. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ Clin Res 2009;339:264–ix.

• Cited Here

[9]. National Centre for Health Statistics [Internet]. Centers for Disease Command and Prevention. Centers for Disease Control and Prevention; 2018 [cited December 6, 2018]. Available from: https://www.cdc.gov/nchs/products/databriefs/db329.htm.

• Cited Here

[10]. Chen LH, Hedegaard H, Warner M. Drug-poisoning deaths involving opioid analgesics: United states of america, 1999-2011. NCHS data brief 2014;i–8.

• Cited Hither

[11]. Iyiewuare PO, McCullough C, Ober A, et al. Demographic and mental wellness characteristics of individuals who present to community health clinics with substance misuse. Health Serv Res Manag Epidemiol 2017;iv:

• Cited Here

[12]. Puffer ES, Skalski LM, Meade CS. Changes in religious coping and relapse to drug apply amid opioid-dependent patients following inpatient detoxification. J Religion Health 2012;51:1226–38.

• Cited Hither

[xiii]. Sloan RP, Bagiella East, VandeCreek L, et al. Should physicians prescribe religious activities. New Engl J Med 2000;342:1913–six.

• Cited Here

[xiv]. Hsu DJ, McCarthy EP, Stevens JP, et al. Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001-12. Habit 2017;112:1558–64.

• Cited Here

[fifteen]. Unick GJ, Ciccarone D. Usa regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations. Int J Drug Policy 2017;46:112–9.

• Cited Here

[16]. Mosher H, Zhou Y, Thurman AL, et al. Trends in hospitalization for opioid overdose amid rural compared to urban residents of the The states. 2007-2014. J Hosp Med 2017;12:925–9.

• Cited Hither

[17]. Penm J, MacKinnon NJ, Boone JM, et al. Strategies and policies to accost the opioid epidemic: a example study of Ohio. J Am Pharm Assoc 2017;57:S148–53.

• Cited Hither

[18]. Kirsh KL, Fishman SM. Multimodal approaches to optimize outcomes of chronic opioid therapy in the management of chronic pain. Pain Med 2011;12(suppl ane):S1–1.

• Cited Here

[19]. Floret North, Viel J-F, Mauny F, et al. Negligible risk for epidemics after geophysical disasters. Emerg Infect Dis 2006;12:543–8.

• Cited Here

[xx]. Hammer R, Dingel M, Ostergren J, et al. Addiction: Current criticism of the brain disease paradigm. AJOB Neurosci 2013;4:27–32.

• Cited Hither

[21]. Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet 2016;387:1644–56.

• Cited Here

[22]. Rudd RA, Aleshire Due north, Zibbell JE, et al. Increases in drug and opioid overdose deaths—U.s.a., 2000-2014. Am J Transpl 2016;16:1323–7.

• Cited Hither

[23]. Manchikanti Fifty, Kaye AM, Kaye AD. Electric current state of opioid therapy and abuse. Curr Pain Headache Rep 2016;20:34.

• Cited Here

[24]. Colon-Berezin C, Nolan ML, Blachman-Forshay J, et al. Overdose Deaths Involving Fentanyl and Fentanyl Analogs—New York City, 2000-2017. Morb Mortal Wkly Rep 2019;68:37.

• Cited Here

[25]. Schuchat A, Houry D, Guy GP. New information on opioid apply and prescribing in the United States. JAMA 2017;318:425–6.

• Cited Here

[26]. Bao Y, Pan Y, Taylor A, et al. Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing past physicians. Health Diplomacy 2016;35:1045–51.

• Cited Here

[27]. Humphreys K. Avoiding globalisation of the prescription opioid epidemic. Lancet 2017;390:437–9.

• Cited Hither

[28]. Fischer B, Rehm J. Revisiting the 'image shift'in opioid use: developments and implications 10 years after. Drug Alcohol Rev 2018;37:S199–202.

• Cited Here

[29]. Robins R. Drug makers now spend $5 billion a year on advertisement. Here's what that buys. Stat News 2016.

• Cited Here

[30]. Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid apply and heroin use. New Engl J Med 2016;374:154–63.

• Cited Here

[31]. Han B, Compton WM, Blanco C, et al. Prescription opioid use, misuse, and use disorders in United states adults: 2015 National Survey on Drug Utilise and Health. Ann Intern Med 2017;167:293–301.

• Cited Here

[32]. Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health 2009;99:221–7.

• Cited Here

[33]. National Institute on Drug Corruption. Fentanyl and Other Synthetic Opioids Drug Overdose Deaths [Internet]. NIDA. 2018 [cited July half-dozen, 2018]. Available from: https://www.drugabuse.gov/related-topics/trends-statistics/infographics/fentanyl-other-constructed-opioids-drug-overdose-deaths

• Cited Hither

[34]. Centers for Affliction Control and Prevention. Guideline for prescribing opioids for chronic pain. Journal of pain & palliative care pharmacotherapy 2016;xxx:138–twoscore.

• Cited Here

[35]. Karila L, Marillier M, Chaumette B, et al. New synthetic opioids: part of a new addiction landscape. Neurosci Biobehav Rev 2018.

• Cited Hither

[36]. https://www.dea.gov/ DEA. Fentanyl Remains the Most Significant Synthetic Opioid Threat and Poses the Greatest Threat to the Opioid User Market in the United states of america [Net]. Homeland Security Digital Library. The states. Drug Enforcement Administration; 2018 [cited May 5, 2018]. Available from: https://www.hsdl.org/?abstract&did=818578.

• Cited Here

[37]. Mars SG, Bourgois P, Karandinos G, et al. Every 'never'I ever said came true": transitions from opioid pills to heroin injecting. Int J Drug Policy 2014;25:257–66.

• Cited Here

[38]. Cicero TJ, Ellis MS, Surratt HL, et al. The irresolute face up of heroin apply in the United States: a retrospective analysis of the past l years. JAMA Psychiatry 2014;71:821–6.

• Cited Here

[39]. Ciccarone D. Heroin in brownish, blackness and white: Structural factors and medical consequences in the The states heroin market. Int J Drug Policy 2009;20:277–82.

• Cited Here

[twoscore]. Mars SG, Fessel JN, Bourgois P, et al. Heroin-related overdose: the unexplored influences of markets, marketing and source-types in the United States. Social Sci Med 2015;140:44–53.

• Cited Here

[41]. Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crunch: a public health arroyo to an epidemic of addiction. Ann Rev Public Wellness 2015;36:559–74.

• Cited Here

[42]. Volkow ND. America's addiction to opioids: heroin and prescription drug abuse. Senate Caucus on International Narcotics Control 2014;14.

• Cited Here

[43]. Opioid Overdoses Treated in Emergency Departments | VitalSigns | CDC [Internet]. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention; [cited May 6, 2018]. Available from: https://www.cdc.gov/vitalsigns/opioid-overdoses/.

• Cited Here

[44]. Liu Y, Logan JE, Paulozzi LJ, et al. Potential misuse and inappropriate prescription practices involving opioid analgesics. Am J Manag Care 2013;19:648–65.

• Cited Here

[45]. Boyd CJ, McCabe SE, Cranford JA, et al. Adolescents' motivations to corruption prescription medications. Pediatrics 2006;118:2472–lxxx.

• Cited Here

[46]. Dash GF, Wilson Air conditioning, Morasco BJ, et al. A model of the intersection of pain and opioid misuse in children and adolescents. Clin Psychol Sci 2018;6:629–46.

• Cited Here

[47]. Gaither JR, Leventhal JM, Ryan SA, et al. National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012. JAMA Pediatr 2016;170:1195–201.

• Cited Here

[48]. McCabe SE, W BT, Teter CJ, et al. Medical and nonmedical use of prescription opioids among high schoolhouse seniors in the United States. Arch Pediatr Adolescent Med 2012;166:797–802.

• Cited Here

[49]. Compton WM, Boyle M, Wargo East. Prescription opioid abuse: problems and responses. Prev Med 2015;eighty:5–9.

• Cited Here

[50]. Han B, Compton WM, Jones CM, et al. Nonmedical prescription opioid employ and use disorders among adults aged 18 through 64 years in the Us, 2003-2013. JAMA 2015;314:1468–78.

• Cited Here

[51]. Finley EP, Garcia A, Rosen K, et al. Evaluating the impact of prescription drug monitoring program implementation: a scoping review. BMC Health Services Res 2017;17:420.

• Cited Here

[52]. White A, Spittle T, Niebler W, et al. (236) A damage reduction model to quantify potential misuse/abuse reduction and misuse/abuse-related events avoided from extended-release corruption deterrent opioids. J Pain 2017;18:S34–five.

• Cited Hither

[53]. Cicero TJ, Ellis MS, Kasper ZA. Relative preferences in the abuse of immediate-release versus extended-release opioids in a sample of handling-seeking opioid abusers. Pharmacoepidemiol Drug Prophylactic 2017;26:56–62.

• Cited Here

[54]. Kelly JP, Cook SF, Kaufman DW, et al. Prevalence and characteristics of opioid use in the US developed population. Hurting 2008;138:507–13.

• Cited Here

[55]. Birnbaum HG, White AG, Schiller K, et al. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med 2011;12:657–67.

• Cited Hither

[56]. FDA. Opioid Medications. 2018. Available at: https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm337066.htm 2018. Accessed July 24, 2018.

• Cited Here

[57]. Rodgers J, Cunningham Yard, Fitzgerald One thousand, et al. Opioid consumption following outpatient upper extremity surgery. J Hand Surg 2012;37:645–50.

• Cited Here

[58]. Hill MV, McMahon ML, Stucke RS, et al. Broad variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg 2017;265:709–fourteen.

• Cited Here

[59]. Katz NP, Birnbaum H, Brennan MJ, et al. Prescription opioid abuse: challenges and opportunities for payers. Am J Manag Care 2013;19:709–14.

• Cited Here

[sixty]. Schatman ME. The American chronic hurting crisis and the media: almost time to get information technology right. J Hurting Res 2015;8:885–7.

• Cited Here

[61]. Schatman ME, Webster LR. The wellness insurance manufacture: perpetuating the opioid crisis through policies of price-containment and profitability. J Hurting Res 2015;8:153–8.

• Cited Here

[62]. Weeks J. Influential US medical organizations phone call for insurance coverage of not-pharmacologic approaches to hurting. J Altern Complementary Med (New York, NY) 2016;22:947–nine.

• Cited Here

[63]. Atkinson TJ, Schatman ME, Fudin J. The harm done by the war on opioids: the pendulum has swung too far. J Pain Res 2014;vii:265–8.

• Cited Here

[64]. McClellan C, Lambdin BH, Ali MM, et al. Opioid-overdose laws association with opioid use and overdose mortality. Addictive Behav 2018;86:90–5.

• Cited Here

[65]. Werle Due north, Zedillo E. We Can't Go Cold Turkey: Why Suppressing Drug Markets Endangers Social club. J Police force Med Ideals 2018;46:325–42.

• Cited Here

[66]. Kremer ME, Arora KS. Clinical, upstanding, and legal considerations in significant women with opioid corruption. Obstetr Gynecol 2015;126:474–eight.

• Cited Hither

[67]. Grigoras CA, Karanika S, Velmahos East, et al. Correlation of opioid mortality with prescriptions and social determinants: a cross-sectional study of medicare enrollees. Drugs 2018;78:111–21.

• Cited Here

[68]. Henney JE, Shuren JE, Nightingale SL, et al. Internet buy of prescription drugs: buyer beware. Ann Intern Med 1999;131:861–2.

• Cited Here

[69]. Rigg KK, Kurtz SP, Surratt HL. Patterns of prescription medication diversion amidst drug dealers. Drugs Instruction Prev Policy 2012;19:145–55.

• Cited Here

[70]. McCabe SE, West BT, Boyd CJ. Leftover prescription opioids and nonmedical use among high schoolhouse seniors: a multi-cohort national written report. J Adolesc Health 2013;52:480–5.

• Cited Here

[71]. Weisberg DF, Becker WC, Fiellin DA, et al. Prescription opioid misuse in the U.s.a. and the United Kingdom: cautionary lessons. Int J Drug Policy 2014;25:1124–xxx.

• Cited Hither

[72]. Bert F, Galis V, Passi Southward, et al. Differences existing betwixt U.s.a. and Europe in opioids purchase on internet: an interpretative review. J Substance Employ 2015;20:200–7.

• Cited Hither

[73]. Van Buskirk J, Roxburgh A, Farrell M, et al. The closure of the S ilk R oad: what has this meant for online drug trading. Habit 2014;109:517–8.

• Cited Here

[74]. Netherland J, Hansen HB. The war on drugs that wasn't: wasted whiteness,"Muddy Doctors," and race in media coverage of prescription opioid misuse. Culture Med Psychiatry 2016;40:664–86.

• Cited Here

[75]. Cicero TJ, Inciardi JA, Muñoz A. Trends in abuse of OxyContin ( and other opioid analgesics in the United States: 2002-2004. J Pain 2005;6:662–72.

• Cited Hither

[76]. McGinty EE, Kennedy-Hendricks A, Baller J, et al. Criminal activity or treatable wellness condition? News media framing of opioid analgesic corruption in the United States, 1998-2012. Psychiatr Serv 2015;67:405–11.

• Cited Hither

[77]. Srivastava A, Kahan G, Nader M. Primary care direction of opioid utilize disorders: abstinence, methadone, or buprenorphine-naloxone. Canad Family Phys 2017;63:200–5.

• Cited Here

[78]. Clark RE, Baxter JD, Aweh G, et al. Risk factors for relapse and higher costs among Medicaid members with opioid dependence or abuse: opioid agonists, comorbidities, and handling history. J Substance Corruption Care for 2015;57:75–80.

• Cited Here

[79]. Wiese HJC, Piercey RR, Clark CD. Changing prescribing behavior in the United states of america: moving upstream in opioid prescription education. Clin Pharmacol Ther 2018;103:982–9.

• Cited Here

[80]. National Academies of Sciences, Engineering, and Medicine. Pain direction and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid employ. National Academies Press; 2017:49–119.

• Cited Here

[81]. U.Due south. Hurting Foundation. Aid support a landmark pain research funding bill [Cyberspace]. U.S. Pain Foundation. 2018 [cited May 6, 2018]. Available from: https://uspainfoundation.org/news/assist-back up-landmark-pain-research-funding-beak/.

• Cited Hither

[82]. Pavlinich M, Perret D, Rivers Nosotros, et al. Physiatry, pain management, and the opioid crisis: a focus on function. Am J Phys Med Rehabil 2018;97:856–lx.

• Cited Here

Keywords:

opioid consumption; opioid epidemic; opioids; over-prescription

Copyright © 2019 the Author(s). Published past Wolters Kluwer Health, Inc.

perezmandred.blogspot.com

Source: https://journals.lww.com/md-journal/Fulltext/2019/05170/Current_perspectives_on_the_opioid_crisis_in_the.10.aspx

Share this post